podophyllotoxin has been researched along with Recrudescence in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (24.49) | 18.7374 |
1990's | 16 (32.65) | 18.2507 |
2000's | 12 (24.49) | 29.6817 |
2010's | 9 (18.37) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellò, M; Benevolo, G; Bisi, G; Boccomini, C; Botto, B; Castellino, A; Chiappella, A; Ciochetto, C; Freilone, R; Nicolosi, M; Orsucci, L; Passera, R; Pecoraro, C; Pregno, P; Vitolo, U | 1 |
Bennett, K; Copas, AJ; Doré, CJ; Gilson, R; Haddow, LJ; Jit, M; Lacey, C; Meadows, J; Murray, ML; Nathan, M; Soldan, K; Tetlow, M | 1 |
Angel-Müller, E; Gaitán, HG; Grillo-Ardila, CF; Lethaby, A; Ruiz-Parra, AI; Salazar-Díaz, LC | 1 |
Christofides, A; Isidori, A; Visani, G | 1 |
Baguley, S; Delaney, E | 1 |
Gilson, RJ; Lacey, CJ; Maw, R; Ross, J; Rowen, D; Sonnex, C | 1 |
Barosi, G; Fanti, S; Gianni, AM; Martelli, M; Petrini, M; Tura, S; Vitolo, U; Zinzani, PL | 1 |
Aureli, V; Balduino, G; Caniglia, M; Cometa, AM; Isacchi, G; Landi, F; Miele, MJ; Pinto, RM; Rana, I; Scerpa, MC; Zinno, F | 1 |
Andersen, NS; Bentzen, H; Brown, P; Delabie, J; Ehinger, M; Elonen, E; Eriksson, M; Geisler, CH; Jerkeman, M; Karjalainen-Lindsberg, ML; Kimby, E; Kolstad, A; Kuittinen, O; Laurell, A; Lauritzsen, GF; Nilsson-Ehle, H; Nordström, M; Pedersen, LB; Ralfkiaer, E; Räty, R; Sundström, C | 1 |
Bucher, C; Buser, A; Gerull, S; Halter, J; Heim, D; O'Meara, A; Passweg, J; Stern, M | 1 |
Armitage, JO; Bierman, PJ; Bociek, RG; Chan, WC; Enke, C; Hankins, J; Loberiza, FR; Vose, JM; Weisenburger, DD | 1 |
Wollina, U | 1 |
Ault, KA | 1 |
Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R | 1 |
Bahlis, N; Balogh, A; Brown, C; Jones, A; Morris, DG; Russell, JA; Savoie, L; Stewart, DA; Valentine, K | 1 |
Balzarotti, M; Bramanti, S; Castagna, L; Magagnoli, M; Mazza, R; Nozza, A; Russo, F; Santoro, A; Sarina, B; Siracusano, L; Timofeeva, I; Todisco, E | 1 |
Blundell, E; Goldstone, AH; Linch, DC; Peggs, KS; Thomson, KJ | 1 |
Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Kalwinsky, DK; Murphy, SB; Rivera, G; Stagner, S; Wood, A | 1 |
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
Aur, RJ; Avery, TL; Dahl, GV; Pratt, CB; Rivera, G; Wood, A | 1 |
Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
Phillips, GL; Reece, DE | 1 |
Brandwein, JM; Colwill, R; Couture, F; Crump, M; Danish, R; Keating, A; Scott, JG; Stewart, AK; Sutcliffe, SB; Sutton, DM | 1 |
Aynaud, O; Tranbaloc, P | 1 |
Shao, Y; Wang, B | 1 |
Kamen, BA; Weitman, SD; Winick, NJ | 1 |
Ahmad, SA; Lundin, S; Syed, TA | 1 |
Bailey-Farchione, A; Bell, R; Bonnez, W; Elswick, RK; Hallahan, D; Isenberg, R; Reichman, RC; Stoler, MH | 1 |
Fleischl, G; Götz, M; Jarisch, R; Wantke, F | 1 |
Billingham, LJ; Knechtli, CJ; Long, SG; Lumley, MA; McDonald, DF; Milligan, DW | 1 |
Downs, SM; Goldberg, SH; Khanna, V; Koenig, JD; Manyak, MJ; Patsner, B; Strauss, MJ | 1 |
Claesson, U; Happonen, H; Hogström, L; Lassus, A; Siboulet, A | 1 |
Batan, ZE; Milanovich, NF; Skriagin, AE; Snegir', VM; Uss, AL; Zmachinskiĭ, VA | 1 |
Andreeff, M; Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, CA; Kornblau, SM; O'Brien, S | 1 |
Barta, A; Batai, A; Kelemen, E; Lengyel, L; Paloczi, K; Petranyi, GG; Sipos, A; Torbagyi, E | 1 |
Aguado, MJ; Canales, MA; de Bustos, JG; Fernández-Jiménez, MC; Hernández-Navarro, F; Ojeda, E | 1 |
Allen, AL; Siegfried, EC | 1 |
Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O | 1 |
Fagnani, F | 1 |
Caballero, MD; Canales, MA; Fernández-Jiménez, MC; García de Bustos, J; Hernández-Navarro, F; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L | 1 |
Ferguson, A; Hewitson, R; Levin, W; Sealy, R; Tucker, RD; Van Wyk, C | 1 |
Mechl, Z; Rovný, F; Sopková, B | 1 |
Artman, NN; Beutner, KR; Conant, MA; Friedman-Kien, AE; Illeman, M; King, DH; Thisted, RA | 1 |
Lassus, A | 1 |
Bezanilla Regato, JL; Moya Calderón, E; Navajas Gutiérrez, A; Piñán, MA | 1 |
Chan, HY; Lewis, JP; Meyers, FJ | 1 |
Cavallin-Ståhl, E; Hagberg, H; Lind, J | 1 |
Estruch, R; Fernandez-Huerta, JM; Montserrat, E; Rozman, C; Urbano-Márquez, A | 1 |
Amiel, JL; Mathé, G | 1 |
9 review(s) available for podophyllotoxin and Recrudescence
Article | Year |
---|---|
Imiquimod for anogenital warts in non-immunocompromised adults.
Topics: Adult; Aminoquinolines; Anus Diseases; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunocompetence; Interferon Inducers; Keratolytic Agents; Male; Podophyllin; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence; Self Administration; Warts | 2014 |
Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Podophyllotoxin; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2016 |
[Genital warts].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Keratolytic Agents; Male; Medical History Taking; Ointments; Podophyllotoxin; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2009 |
Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine.
Topics: Antineoplastic Agents; Condylomata Acuminata; Cryosurgery; Female; Humans; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Recurrence; Viral Vaccines | 2003 |
Intensive therapy and autotransplantation in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Digestive System Diseases; Etoposide; Heart Diseases; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lung Diseases; Melphalan; Multicenter Studies as Topic; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1994 |
"Above all do no harm:" horizons in pediatric oncology.
Topics: Bone Marrow Transplantation; Child; Combined Modality Therapy; Growth Substances; Humans; Leukemia, Myeloid, Acute; Medical Oncology; Mercaptopurine; Methotrexate; Pediatrics; Phenotype; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Recurrence; Survival Rate | 1994 |
The cost of treating genital warts.
Topics: Clinical Protocols; Condylomata Acuminata; Cost-Benefit Analysis; Cryotherapy; Fees, Medical; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Health Care Costs; Humans; Insurance, Health, Reimbursement; Keratolytic Agents; Laser Therapy; Male; Models, Economic; Podophyllin; Podophyllotoxin; Recurrence; Relative Value Scales; Remission Induction; Sex Factors; Trichloroacetic Acid | 1996 |
What's new in human papillomavirus infection.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child; Cidofovir; Cimetidine; Cytosine; Histamine H2 Antagonists; Humans; Hypnosis; Imiquimod; Keratolytic Agents; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Podophyllotoxin; Recurrence; Risk Factors; Warts | 2000 |
[Medico-economic analysis of therapy of external condylomata acuminata].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Drug Evaluation; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Laser Therapy; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence | 2000 |
18 trial(s) available for podophyllotoxin and Recrudescence
Article | Year |
---|---|
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Invasiveness; Podophyllotoxin; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2018 |
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurr
Topics: Adult; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Recurrence; Treatment Outcome; Vaccination | 2018 |
A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
Topics: Adolescent; Adult; Antiviral Agents; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Double-Blind Method; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Ointments; Podophyllotoxin; Recurrence; Treatment Outcome; Urologic Diseases; Young Adult | 2009 |
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Recurrence; Rituximab; Survival Rate; Transplantation, Autologous | 2012 |
Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Melphalan; Middle Aged; Myeloablative Agonists; Podophyllotoxin; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2013 |
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2013 |
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2006 |
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Confidence Intervals; Critical Care; Cytarabine; Erythrocyte Transfusion; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neutropenia; Platelet Transfusion; Podophyllotoxin; Preoperative Care; Prognosis; Recurrence; Salvage Therapy; Time Factors | 1995 |
[Treatment of external ano-genital condylomata with 0.5% podophyllotoxin].
Topics: Adult; Anus Diseases; Condylomata Acuminata; Female; Humans; Male; Penile Diseases; Podophyllotoxin; Prospective Studies; Recurrence; Treatment Outcome; Vulvar Diseases | 1995 |
[A primary clinical trial of genital warts treated with domestic highly purified podophyllotoxin].
Topics: Adult; Condylomata Acuminata; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Middle Aged; Podophyllotoxin; Recurrence | 1994 |
Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
Topics: Administration, Topical; Adolescent; Adult; Condylomata Acuminata; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emulsions; Female; Genital Diseases, Female; Humans; Pakistan; Podophyllotoxin; Recurrence; Remission Induction; Self Administration; Time Factors | 1994 |
Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
Topics: Adult; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Dermatitis, Contact; Double-Blind Method; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Pain; Placebos; Podophyllotoxin; Pruritus; Recurrence; Remission Induction; Safety | 1994 |
High lactate dehydrogenase level is associated with an adverse outlook in autografting for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Recurrence; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1996 |
Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution.
Topics: Administration, Topical; Adult; Condylomata Acuminata; Female; Humans; Keratolytic Agents; Male; Ointments; Penile Diseases; Podophyllotoxin; Recurrence; Solutions; Vulvar Diseases | 1996 |
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy | 1998 |
Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carmustine; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 1999 |
Patient-applied podofilox for treatment of genital warts.
Topics: Administration, Topical; Adult; Condylomata Acuminata; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Multicenter Studies as Topic; Penile Diseases; Podophyllotoxin; Random Allocation; Recurrence; Self Administration | 1989 |
Comparison of podophyllotoxin and podophyllin in treatment of genital warts.
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; Male; Penile Diseases; Podophyllin; Podophyllotoxin; Random Allocation; Recurrence; Warts | 1987 |
22 other study(ies) available for podophyllotoxin and Recrudescence
Article | Year |
---|---|
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Hematology; Humans; Italy; Lymphoma, Non-Hodgkin; Melphalan; Podophyllotoxin; Practice Guidelines as Topic; Recurrence; Societies, Medical; Time Factors | 2010 |
Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Preservation; Carmustine; Cell Count; Child, Preschool; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunomagnetic Separation; Leukapheresis; Lymphoma, Large-Cell, Anaplastic; Melphalan; Podophyllotoxin; Recurrence; Transplantation, Autologous | 2010 |
Er:YAG laser followed by topical podophyllotoxin for hard-to-treat palmoplantar warts.
Topics: Administration, Topical; Adolescent; Adult; Female; Foot Dermatoses; Hand Dermatoses; Humans; Keratolytic Agents; Laser Therapy; Male; Middle Aged; Papillomaviridae; Podophyllotoxin; Recurrence; Treatment Outcome; Warts | 2003 |
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Vinblastine; Vinorelbine | 2007 |
A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Podophyllotoxin; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2007 |
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Recurrence; Teniposide; Vincristine | 1982 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypotension; Leukemia, Lymphoid; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide | 1980 |
Retrieval therapy for isolated CNS relapse in childhood acute lymphoblastic leukemia.
Topics: Brain Neoplasms; Child; Humans; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1995 |
Topical podophyllotoxin in psoriasis vulgaris.
Topics: Administration, Cutaneous; Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Podophyllotoxin; Psoriasis; Recurrence | 1993 |
[Hemopoietic stem cell transplantation in lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carmustine; Child; Cytarabine; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Male; Melphalan; Podophyllotoxin; Recurrence; Treatment Outcome | 1997 |
Haemopoietic cell transplantation activity and results: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Hungary; Leukemia; Melphalan; Podophyllotoxin; Recurrence; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 1998 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine | 2000 |
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Carmustine; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Recurrence; Salvage Therapy; Sex Factors; Survival Analysis; Transplantation, Autologous | 2001 |
Chemotherapy of small cell carcinoma of the lung with V.P. 16-213.
Topics: Bone Marrow; Carcinoma, Small Cell; Disability Evaluation; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Time Factors | 1978 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Topics: Child; Child, Preschool; Cytarabine; Drug Combinations; Female; Humans; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; Teniposide | 1988 |
High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Female; Humans; Leukemia; Liver; Male; Middle Aged; Podophyllotoxin; Recurrence; Time Factors | 1987 |
Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Podophyllotoxin; Recurrence | 1986 |
Etoposide in the treatment of multifocal eosinophilic granuloma.
Topics: Bone Diseases; Eosinophilic Granuloma; Etoposide; Female; Gingival Diseases; Humans; Middle Aged; Podophyllotoxin; Recurrence; Vulvar Diseases | 1985 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine | 1974 |